Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Mid-range Performer
1921.7000 -31.30 (-1.60%)
NSE Sep 26, 2025 15:31 PM
Volume: 4,541
 

1921.70
-1.60%
Karvy
Domestic Brucella and PPR Vaccines Sales Drive Profitability: A surprise and significant jump in domestic Large Animal Vaccines (LAV) sales - primarily Brucella vaccine and to smaller degree PPR vaccines - have led to considerableexpansion in gross margin and EBITDA margin.
Hester Biosciences Ltd. is trading below its 30 day SMA of 2036.6
More from Hester Biosciences Ltd.
Recommended